Skip to main content

Software and artificial intelligence are increasingly central to modern healthcare technologies. At the same time, the Medical Device Regulation, In Vitro Diagnostic Regulation, and the EU Artificial Intelligence Act introduce specific regulatory requirements for the development, validation, and commercialization of these solutions.

Understanding these requirements early is essential for successful development and market access.

The European regulatory framework for medical devices and in vitro diagnostics has undergone significant changes with the implementation of the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).

These changes directly affect research institutions, startups, and innovation teams developing new healthcare technologies and preparing them for market entry.

BioPhoT

In the second Research and Innovation Project (PIP) call of the BioPhoT research platform, funding has been awarded to 26 projects, as decided by the Platform’s Project Management Group on 20 February. Among the approved initiatives are two projects led by researchers from Rīga Stradiņš University (RSU).

Mākslīgais intelekts "Data Science Conference Europe 2025"

From 18 to 22 November, Rīga Stradiņš University (RSU) Data Steward Laura Badūne (pictured) participated in the Data Science Conference Europe in Belgrade, Serbia. The conference brought together industry experts, data scientists, data engineers, and analysts, as well as researchers and academics, business and team leaders, and other representatives who work on a daily basis or are interested in the opportunities provided by artificial intelligence (AI) and its use in data-related industries.

Subscribe to